Sun Pharma Q2 Review: Brokerages Largely Bullish On Portfolio Growth, Healthy Margins
Citi said Sun's healthy margins should ease investor concerns, while Morgan Stanley highlighted that Sun maintained leadership in India.
What's Your Reaction?